MKM Partners analyst William Kirk reiterated a Hold rating on HEXO (HEXO) today and set a price target of C$1.00. The company’s shares closed last Monday at $0.79, close to its 52-week low of $0.35.
According to TipRanks.com, Kirk is ranked #5106 out of 6216 analysts.
HEXO has an analyst consensus of Moderate Sell, with a price target consensus of $1.16, implying a 24.7% upside from current levels. In a report issued on March 17, Oppenheimer also maintained a Hold rating on the stock.
See today’s analyst top recommended stocks >>
Based on HEXO’s latest earnings release for the quarter ending October 31, the company reported a quarterly revenue of $14.5 million and GAAP net loss of $60.02 million. In comparison, last year the company earned revenue of $5.66 million and had a GAAP net loss of $12.8 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.
Read More on HEXO: